OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: James Bennett

2 Projects | 1 Researchers | $701,200 Invested

2013

Virginia Commonwealth University

James Bennett

Increasing Mitochondrial Biogenesis in Alzheimer's Disease

  • Funding Amount: $200,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2010

Virginia Commonwealth University

James Bennett

Safety/Tolerability and Effects on Cognitive Impairment, Impaired Cerebral Cortical Metabolism and Oxidative Stress of R(+)Pramipexole Administered to Subjects with Early Alzheimer's Disease

  • Funding Amount: $501,200
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Mitochondria/Metabolic Function
  • Status: Closed